Celsion Corporation Announces Company Name Change to Imunon, Inc.

September 19, 2022

https://www.globenewswire.com/news-release/2022/09/19/2518734/0/en/Celsion-Corporation-Announces-Company-Name-Change-to-Imunon-Inc.html

New name reflects the evolution of the Company’s business focus and its commitment to immunotherapies and vaccines

LAWRENCEVILLE, N.J., Sept. 19, 2022 (GLOBE NEWSWIRE) — Celsion Corporation (NASDAQ:CLSN), a clinical-stage drug development company, today announced a company name change to Imunon, Inc., reflecting the evolution of the Company’s business focus and its commitment to developing cutting-edge immunotherapies and next-generation vaccines to treat cancer and infectious diseases.

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.